CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,737,076 | -61.1% | 2,794,542 | -44.3% | 0.75% | -58.0% |
| Q4 2022 | $30,149,327 | +43.4% | 5,016,527 | +38.9% | 1.79% | +46.3% |
| Q3 2022 | $21,024,000 | +30.2% | 3,612,376 | +33.6% | 1.22% | -9.1% |
| Q2 2022 | $16,146,000 | +77.1% | 2,704,510 | +38.5% | 1.34% | +94.4% |
| Q1 2022 | $9,119,000 | +49.0% | 1,952,691 | -5.9% | 0.69% | +91.2% |
| Q3 2021 | $6,120,000 | +1326.6% | 2,074,714 | +1108.9% | 0.36% | +1348.0% |
| Q2 2021 | $429,000 | – | 171,619 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|